Daniel Carper

Title: The Innovations of Daniel Carper

Introduction

Daniel Carper is an accomplished inventor based in Wilmington, Delaware. He has made significant contributions to the field of pharmaceuticals, particularly in the development of PD-1/PD-L1 inhibitors. With a total of two patents to his name, Carper's work is instrumental in advancing treatments for various diseases, including cancer.

Latest Patents

Carper's latest patents focus on the process for making a PD-1/PD-L1 inhibitor and its salts and crystalline forms. These patents detail the processes and intermediates necessary for the preparation of the PD-1/PD-L1 inhibitor, specifically the compound (R)-1-((7-cyano-2-(3'-((2-(difluoromethyl)-7-((3-hydroxypyrrolidin-1-yl)methyl)pyrido[3,2-d]pyrimidin-4-yl)amino)-2,2′-dimethyl-[1,1′-biphenyl]-3-yl)benzo[d]oxazol-5-yl)methyl)piperidine-4-carboxylic acid. This compound and its solid and salt forms are crucial for the treatment of infectious diseases and cancer.

Career Highlights

Carper is currently employed at Incyte Corporation, where he continues to innovate in the pharmaceutical industry. His work has garnered attention for its potential impact on treatment methodologies and patient outcomes.

Collaborations

Throughout his career, Carper has collaborated with notable colleagues, including Dengjin Wang and Zhongjiang Jia. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Daniel Carper's contributions to the field of pharmaceuticals through his innovative patents highlight his role as a key inventor in the industry. His work on PD-1/PD-L1 inhibitors is paving the way for new treatment options for serious diseases.